Celltheon Corporation Discusses the Adoption of Single-Use Bioreactors

InfoWeb Marketplace

Saturday, September 14, 2019Description :
Divya Goel, MBS of Celltheon Corporation discusses the role of Allegro™ STR single-use bioreactors in meeting the changing monoclonal antibody (mAb) bioprocessing challenges and to avoid operating inefficiencies in the future. Learn more at https://biotech.pall.com/en/cell-culture/stirred-tank-bioreactors.html

Searches related toLaboratory equipment

Grouped quotes (0)